Comparative Efficacy and Safety of Colchicine and Anti–Interleukin‐1 Agents in Recurrent Pericarditis: A Pairwise and Network Meta‐Analysis of Randomized Controlled Trials
Background The management of recurrent pericarditis includes colchicine and anti–interleukin‐1 agents, given the limited efficacy and adverse effects of NSAIDs and corticosteroids. We conducted a pairwise and network meta‐analysis to evaluate the efficacy and safety of colchicine and anti–interleuki...
Saved in:
Main Authors: | Muhammad Ehsan, Alveena Batool Syed, Biah Mustafa, Jibran Ikram, Muhammad Hammad Khan, Paul C. Cremer, Massimo Imazio, Tom Kai Ming Wang, Allan L. Klein |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-07-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.125.041007 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pericarditis as an interdisciplinary problem. In anticipation of the update of the European Society of Cardiology guidelines
by: Massimo Imazio, et al.
Published: (2024-09-01) -
Problems of immunopathology and prospects for pharmacotherapy of idiopathic recurrent pericarditis: Using an interleukin 1 inhibitor (Anakinra)
by: E. L. Nasonov, et al.
Published: (2023-03-01) -
Colchicine: Repositioning an “ancient” medicine in the 21st century
by: E. L. Nasonov, et al.
Published: (2018-06-01) -
Colchicine: Repositioning an “ancient” medicine in the 21<sup>st</sup> century
by: E. L. Nasonov, et al.
Published: (2024-11-01) -
Pericarditis. Clinical Guidelines 2022
by: G. P. Arutyunov, et al.
Published: (2023-04-01)